Your browser doesn't support javascript.
loading
Profiles of glaucoma medication / 国际眼科杂志(Guoji Yanke Zazhi)
International Eye Science ; (12): 807-809, 2015.
Article in Zh | WPRIM | ID: wpr-637357
Responsible library: WPRO
ABSTRACT
?As a globally recognized irreversible blindness disease, glaucoma can lead to pathological intraocular hypertension, loss of optic ganglion cells and axonal progressive, more and more deep optic cup, and the expanded visual field defect. Various researches show that excitatory amino acid toxicity, oxidative damage, apoptosis, intracellular Ca2+overloading etc. , pathogenic factors are all involved in the occurrence and development of glaucoma. Now, a variety of clinical drugs and operation treatment are applied to control the glaucoma progress. Further more, there are many new drugs and methods in the process of development. This is an article on the current anti-glaucoma drugs.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: International Eye Science Year: 2015 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: International Eye Science Year: 2015 Type: Article